Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Nov 10, 2025 · Filed Nov 12, 2025
Aptiv's CLO, CCO & Secretary sold $1.09M of Aptiv shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,092,000
Shares × reported transaction price
11 days after results of Oct 30, 2025, 84 days before results of Feb 2, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $82.56 on Nov 10, 2025, 72% above its 52-week low and 6% below its high, after a 4% drop over the previous 30 trading days
52-week range $47.92 (Apr 11, 2025) to $87.98 (Oct 3, 2025), 86% of the way up, from 250 adjusted closes. 30 trading days earlier: $85.77 on Sep 29, 2025. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -13.3% | -2.9% | -10.4% |
| 30 days | -4.6% | +1.3% | -5.9% |
| 90 days | +3.3% | +3.0% | +0.4% |
| 180 days | -32.2% | +9.8% | -42.0% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
